$192.94
00.00%
Pre-Market: 4:53 PM EDT
15 minutes delayed
AbbVie reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AbbVie using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $2.65 | $2.57 | 3.11 % |
Mar 2024 | 2024-04-26 | $2.31 | $2.23 | 3.59 % |
Dec 2023 | 2024-02-02 | $2.79 | $2.77 | 0.72 % |
Sep 2023 | 2023-10-27 | $2.95 | $2.86 | 3.15 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $14.46B | $14.03B | 3.08 % |
Mar 2024 | 2024-04-26 | $12.31B | $11.92B | 3.27 % |
Dec 2023 | 2024-02-02 | $14.30B | $14.02B | 2.00 % |
Sep 2023 | 2023-10-27 | $13.93B | $13.70B | 1.66 % |
AbbVie (ABBV) is scheduled to report earnings on October 25, 2024. The last reported earnings were for reported on July 25, 2024 for Q2.
The Actual EPS was $2.65, which beat the estimate of $2.57.
The Actual Revenue was $14.5B, which beat the estimate of $14B.
Browse earnings estimates, EPS, and revenue on all stocks.